Brief: Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portfolio
May 23 (Reuters) - Hydreight Technologies Inc NURS.V :
* VICTORY SQUARE COMPANY ANNOUNCES ACCESS TO TIRZEPATIDE AND
GLP-1
INJECTIONS TO ITS WEIGHT LOSS PORTFOLIO
Source text for Eikon: ID:nGNX9ZmWdp
Further company coverage: NURS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydreight Technologies
See all newsBrief: Hydreight Technologies Inc. Announces Strategic Investment In Insu Therapeutics To Advance Needle-Free Peptide Delivery Technology
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent
Brief: Hydreight Announces Closing Of Its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise Of Over-Allotment Option
Brief: Hydreight Announces Up To $10 Million Convertible Debenture Offering
Brief: Hydreight Technologies Appoints Roebuck As Director